Albendazole in the treatment of hepatic and intra-abdominal hydatidosis

H. Vildósola, L. Sanchéz, R. Espinoza

Resultado de la investigación: Contribución a una revistaArtículorevisión exhaustiva

4 Citas (Scopus)

Resumen

Albendazole, in doses of 10 mg/kg/day for 28 days with 14 days rest periods between series and series, with a minimum of 3 and a maximum 6 series was administered to 16 patients, 13 women and 3 men, with hepatic and/or of the abdominal cavity hydatid cysts. Clinical, immunological and ultrasonographic criterion were used to evaluate the response, obtaining the following results: complete cure in 6 patients (37.5%), improvement in 7 patients (43.7%) and without change in 3 (18.7%). Drug was tolerated, occurring only one case of reversible total alopecia. There were not abnormalities in liver and renal function tests or in the haematological indices. As conclusion, Albendazole is a good therapeutic alternative in cases of inoperable or multiple hydatid cysts.
Idioma originalInglés estadounidense
Páginas (desde-hasta)17-23
Número de páginas7
PublicaciónRevista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru
EstadoPublicada - 1 dic 1989

Huella Profundice en los temas de investigación de 'Albendazole in the treatment of hepatic and intra-abdominal hydatidosis'. En conjunto forman una huella única.

Citar esto